An investigation into the prevalence of macular damage associated with long-term Tamoxifen use

By Charlotte Hough BSc(Hons) FBDO The General Optical Council (GOC, 2010) has outlined the important role that the dispensing optician (DO) must play in ophthalmic practice. With a duty of care, DOs must have an understanding of drugs and health conditions which may affect the patient’s ocular health, as well being able to give clear and accurate advice. Tamoxifen is an antioestrogen drug used to treat breast cancer, although occasionally high doses may be used in the treatment of brain malignancies. The British National Formulary (BNF, 2014) record blurred and reduced vision as a potential, although, rare side effect. *These articles are kindly provided by the Association of British Dispensing Opticians.*



This page is only available to IOA members. In order to view the full article, please login or register.